Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies.

E, Race; E, Dam; V, Obry; S, Paulous; F, Clavel

doi:10.1097/00002030-199910220-00008

Public

Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies.

Shared by NobleBlocks on Oct 1, 1999 • 12:00 AM UTC

Authors:

Race E

Dam E

Obry V

Abstract

Objective To assess the patterns of HIV phenotypic cross-resistance to protease inhibitors (PI) in patients experiencing viral load rebound on combination therapy including a PI.Methods Phenotypic analysis of sensitivity to indinavir, nelfinavir, saquinavir, ritonavir and amprenavir was carried out ...

Discussions